Search - tctmd.com

Displaying 21 - 40 of 8105

Sort: Relevancy | Date

News Daily News

Good News for Intravascular Imaging Continues at 5 Years: RENOVATE-COMPLEX-PCI

Caitlin E. Cox

March 10, 2026

News Daily News

Digital Data May Sway Intensive BP Treatment in the Elderly

L.A. McKeown

March 09, 2026

Should Moderate FMR Should Be Treated With M-TEER? Experts Duke It Out

News Conference News THT 2026

Should Moderate FMR Be Treated With M-TEER? Experts Duke It Out

Todd Neale

March 06, 2026

News Daily News

Many PE Teams Embraced Mechanical Thrombectomy Early On: PERT Registry

L.A. McKeown

March 06, 2026

News Daily News

Advanced HF in Finland: Costs, Survival Diverge for Elective vs Urgent LVAD

Caitlin E. Cox

March 06, 2026

News Conference News THT 2026

Baroreflex Activation for Advanced HF Yields Positive Results: Postmarketing Data

Todd Neale

March 05, 2026

News Conference News THT 2026

Optimal BP After HeartMate 3 LVAD May Be Higher Than Previously Thought

Todd Neale

March 04, 2026

News Conference News CRT 2026

CRT 2026: What to Expect in Washington, DC

L.A. McKeown

March 04, 2026

Presentation THT 2026

The Microtech System: Turning Implants into Smart Devices

Presenter: Yoram Richter

March 04, 2026

Presentation THT 2026

Statistical Approaches for Developing Credible Evidence of Safety and Effectiveness for HF Devices From Real World Data: An Overview for the Clinician

Presenter: Issa Dahabreh

March 04, 2026

Presentation THT 2026

Mi-VAD: The 4th Generation Ventricular Assist Device - moving away from the apical cannulation paradigm: LVAD, RVAD and biventricular assist. Finally the prospect of universal cardiac support

Presenter: Sudhir Kushwaha

March 04, 2026

Presentation THT 2026

Real World Databases: What Is Required for Their Use To Substitute for Randomized Trials for Device Approvals, Reimbursement and Label Expansion

Presenter: Robert W. Yeh

March 04, 2026

Presentation THT 2026

Cutaneous device and machine learning could estimate pulmonary capillary wedge pressure in patients with heart failure

Presenter: Remi Sabatier

March 04, 2026

Presentation THT 2026

Time for a Separate Guideline Path for HF Devices?

Presenter: Javed Butler

March 04, 2026

Presentation THT 2026

Clinical Feasibility Study of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in Patients with Cardiogenic Shock (ELEVATE™ CS FIH)

Presenter: David Israeli

March 04, 2026

Presentation THT 2026

Revisiting Surrogate Endpoints in Clinical Trials of HF Devices

Presenter: James Januzzi

March 04, 2026

Presentation THT 2026

The Elephant in the Room: How To Deal With PROs in Non-Sham Controlled Studies

Presenter: Gregg W. Stone

March 04, 2026

Presentation THT 2026

Revisiting Patient Reported Outcomes — Can they Be Improved for Device Trials and Account for Mortality?

Presenter: John A. Spertus

March 04, 2026

Presentation THT 2026

The Path Most Traveled: An Overview of the Breakthrough Device Designation — Can It Be Improved?

Presenter: JoAnn Lindenfeld

March 04, 2026

Presentation THT 2026

Sustained Passive Physiologic Monitoring Using a Device-Agnostic AI-Enabled Platform: A Pilot Study in Chronic Heart Failure Patients

Presenter: Afnan Tariq

March 04, 2026

Advertisement

Good News for Intravascular Imaging Continues at 5 Years: RENOVATE-COMPLEX-PCI

Digital Data May Sway Intensive BP Treatment in the Elderly

Should Moderate FMR Be Treated With M-TEER? Experts Duke It Out

Many PE Teams Embraced Mechanical Thrombectomy Early On: PERT Registry

Advanced HF in Finland: Costs, Survival Diverge for Elective vs Urgent LVAD

Baroreflex Activation for Advanced HF Yields Positive Results: Postmarketing Data

Optimal BP After HeartMate 3 LVAD May Be Higher Than Previously Thought

CRT 2026: What to Expect in Washington, DC

The Microtech System: Turning Implants into Smart Devices

Statistical Approaches for Developing Credible Evidence of Safety and Effectiveness for HF Devices From Real World Data: An Overview for the Clinician

Mi-VAD: The 4th Generation Ventricular Assist Device - moving away from the apical cannulation paradigm: LVAD, RVAD and biventricular assist. Finally the prospect of universal cardiac support

Real World Databases: What Is Required for Their Use To Substitute for Randomized Trials for Device Approvals, Reimbursement and Label Expansion

Cutaneous device and machine learning could estimate pulmonary capillary wedge pressure in patients with heart failure

Time for a Separate Guideline Path for HF Devices?

Clinical Feasibility Study of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in Patients with Cardiogenic Shock (ELEVATE™ CS FIH)

Revisiting Surrogate Endpoints in Clinical Trials of HF Devices

The Elephant in the Room: How To Deal With PROs in Non-Sham Controlled Studies

Revisiting Patient Reported Outcomes — Can they Be Improved for Device Trials and Account for Mortality?

The Path Most Traveled: An Overview of the Breakthrough Device Designation — Can It Be Improved?

Sustained Passive Physiologic Monitoring Using a Device-Agnostic AI-Enabled Platform: A Pilot Study in Chronic Heart Failure Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content